Squamous blepharitis left lower eyelid
ICD-10 H01.025 is a billable code used to indicate a diagnosis of squamous blepharitis left lower eyelid.
Squamous blepharitis is an inflammatory condition affecting the eyelid margins, characterized by the presence of squamous debris and crusting. The left lower eyelid is specifically involved in this code, indicating a localized manifestation. Clinically, patients may present with symptoms such as redness, itching, burning, and a gritty sensation in the eye. The anatomy involved includes the eyelid skin, meibomian glands, and the conjunctival surface. Disease progression can lead to chronic inflammation, potential scarring, and secondary infections if left untreated. Diagnostic considerations include a thorough history and physical examination, often supplemented by slit-lamp examination to assess the extent of eyelid involvement and rule out other conditions such as seborrheic blepharitis or bacterial infections. Treatment typically involves eyelid hygiene, warm compresses, and possibly topical antibiotics or corticosteroids to reduce inflammation and manage symptoms.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H01.025 specifically covers squamous blepharitis localized to the left lower eyelid. It is characterized by flaky skin and crusting along the eyelid margin, often associated with symptoms of irritation and inflammation.
H01.025 should be used when the clinical presentation specifically indicates squamous blepharitis affecting the left lower eyelid. It is important to differentiate it from other types of blepharitis, such as seborrheic or bacterial, which have different codes.
Documentation should include a detailed patient history, physical examination findings, and any diagnostic tests performed. Notes should clearly describe the symptoms, location of the condition, and treatment plan to support the use of H01.025.
